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The  aim  of this  study  was to evaluate  the antimicrobial  activity  of  lapachol,  -lapachone,  -lapachone
and  six  antimicrobials  (ampicillin,  amoxicillin/clavulanic  acid,  cefoxitin,  gentamicin,  ciproﬂoxacin  and
meropenem)  against  twelve  strains  of  Staphylococcus  aureus  from  which  resistance  phenotypes  were
previously  determined  by  the disk  diffusion  method.  Five  S. aureus  strains  (LFBM  01,  LFBM  26, LFBM  28,
LFBM  31 and  LFBM  33)  showed  resistance  to all antimicrobial  agents  tested  and  were selected  for  the  study
of  the  interaction  between  -lapachone  and  antimicrobial  agents,  busing  checkerboard  method.  The
criteria  used  to evaluate  the synergistic  activity  were  deﬁned  by the  Fractional  Inhibitory  Concentration
Index  (FICI).  Among  the  naphthoquinones,  -lapachone  was  the most  effective  against  S.  aureus  strains.ractional Inhibitory Concentration Index FICI  values  ranged  from  0.07 to  0.5, suggesting  a synergistic  interaction  against  multidrug  resistant  S.
aureus  (MRSA)  strains.  An additive  effect  was  observed  with  the  combination  -lapachone/ciproﬂoxacin
against  the  LFBM  33  strain.  The  combination  of  -lapachone  with  cefoxitin  showed  no  added  beneﬁt
against  LFBM  31  and LFBM  33 strains.  This  study  demonstrated  that, in  general,  -lapachone  combined
with  beta  lactams  antimicrobials,  ﬂuoroquinolones  and  carbapenems  acts  synergistically  inhibiting  MRSA
strains.
© 2013 Elsevier GmbH. All rights reserved.ntroduction
Staphylococcus aureus is the common etiological agent of differ-
nt kinds of infections, affecting several tissues and organs and that
as been frequently isolated from community acquired and noso-
omial infections. The increased prevalence of methicillin resistant
taphylococcus aureus strains (MRSA) poses a serious problem to
ospitalized patients and their care providers (Guzmán-Blanco
t al. 2009; Coombs et al. 2011).
This pathogen has developed numerous strategies to resist the
ction of several antimicrobial agents mainly by an array of efﬂux
umps. These mechanisms have been identiﬁed as one of the main
ontributors to multi resistance in Staphylococcus aureus (Gibbons
004; Johari et al. 2012). Thus, the search for new antimicrobial
gents or resistance modifying agents is important as well as the
stablishment of alternative therapies in order to handle this com-
lex infection (Mohtar et al. 2009).
The screening of secondary metabolites of different sources
uch as microorganisms, algae and higher plants are promising to
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ttp://dx.doi.org/10.1016/j.phymed.2013.08.010provide diverse bioactive compounds with different pharmacolog-
ical activities, including antimicrobials (Chung et al. 2011).
The therapeutic potential of phytochemicals for the develop-
ment of anti-MRSA agents has been progressively recognized.
Several studies have been conducted using phytochemicals com-
bined with antimicrobial agents. These interactions can enhance
the efﬁcacy of the antimicrobial agents and are an alternative to
treat infections caused by multi-drug resistant microorganisms,
especially MRSA strains for which an effective therapy is limited
and expensive (Lee et al. 2010; An et al. 2011; Celenza et al. 2012).
Naphthoquinones are phytochemicals with a large pharmaco-
logical activity and have been widely used for industrial purposes
(Silva et al. 2003; Hussain et al. 2007). -Lapachone (3,4-dihydro-
2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione) and its isomer,
-lapachone are natural naphthoquinones extracted from the bark
of the Lapacho tree (Tabebuia avellanedae) or synthesized from
lapachol or lomatiol. They are known to have a variety of phar-
macological properties, including antitumor, anti-inﬂammatory,
anti-trypanosome, anti-malarial, antimicrobial activities and heal-
ing action (Ferreira et al. 2010; Fu et al. 2011; Kumagai et al. 2012).
They can also act as inhibitors of the transcriptase reverse on HIV-1
and topoisomerases in eukaryotes and prokaryotes cells (Kobayashi
et al. 2011).
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Few studies have been focused on the growth inhibitory activ-
ty of the lapachol and its derivatives ( and -lapachone) against
RSA strains (Pereira et al. 2006; Machado et al. 2003). More-
ver, studies on effect of -lapachone combined with antimicrobial
gents against MRSA have not been published so far.
Based on the above description, the aim of the present study
as to determine the in vitro interaction of -lapachone and con-
entional antimicrobials against MRSA strains, as well its ability to
mprove these antibiotic action.
aterials and methods
acterial strains and inocula standardization
The cultures of Staphylococcus aureus (n = 12) were obtained
rom stock cultures and maintained at our laboratory (Laboratório
e Fisiologia e Bioquímica de Micro-organismos-LFBM). They were
solated from clinical specimens (LFBM 05, LFBM 08, LFBM 16, LFBM
6, LFBM 28, LFBM 29, LFBM 30, LFBM 31, LFBM 32, and LFBM
3) and food (LFBM 01). S. aureus ATCC 25923 was  used as the
tandard strain. All bacterial strains were cultured on sheep blood
gar and they were stored in brain heart infusion (BHI) plus glyc-
rol 20% (v/v) after being identiﬁed (Koneman et al. 2008). All S.
ureus strains used in this study showed a resistance phenotype
o several antimicrobial agents such as beta-lactams, aminoglyco-
ides, macrolides, ﬂuoroquinolones, tetracycline, chloramphenicol,
nd lincosamides by the disk method assay. These strains were
ultured onto Mueller-Hinton Agar (MHA) (Acumedia Manufactur-
rs, Baltimore, USA) and incubated at 37 ◦C for 18 h. Single colonies
ere selected and inoculated into Mueller-Hinton broth (Acume-
ia Manufacturers, Baltimore, USA) to turbidity comparable to that
f 0.5 McFarland standard, which is equivalent to a bacterial count
f approximately 108 CFU/ml. After that, the bacterial suspension
as diluted in saline to obtain a ﬁnal inoculum (107 CFU/ml).
ntimicrobial agents
Lapachol was extracted from Tabebuia avellanedae sawdust. The
xtraction of lapachol and the synthesis of  and -lapachone were
arried out at the Department of Antibiotics, Federal University
f Pernambuco-Brazil, according to the methodology described by
ima et al. (1962).
Ampicillin, amoxicillin/clavulanic acid, cefoxitin, ciproﬂoxacin,
entamicin and meropenem were provided by Eurofarma Labora-
ory LTDA – Brazil. Resistance was deﬁned for each case: ampi-
illin (AMP, MIC  ≥ 0.25 g/ml); amoxicillin/clavulanic acid (AMC,
IC  ≥ 8 g/ml); cefoxitin (CFO, MIC  ≥ 4 g/ml); ciproﬂoxacin (CIP,
IC  ≥ 4 g/ml); gentamicin (GEN, MIC  ≥ 8 g/ml) and meropenem
MER, MIC  ≥ 16 g/ml) according to the criteria established by
he Clinical Laboratory Standard Institute (CLSI 2010). The naph-
hoquinones were solubilized in dimethylsulfoxide/tween80/H2O
1.0/0.5/8.5) while the antimicrobial agents were solubilized in
ater.
ntimicrobial activity
The Minimal Inhibitory Concentration (MIC) test was per-
ormed by using the microdilution broth method, following
he recommendations established by CLSI (2010), with some
odiﬁcations. Serial 2-fold dilutions of lapachol, -lapachone,
-lapachone and antimicrobial agents were prepared in ster-
le 96-well microplates containing Mueller Hinton broth (MHB).
ive microliters of the bacterial suspension were inoculated in
ach well to give a ﬁnal concentration of 104 CFU. Antimicrobial
oncentrations ranged from 1024 to 0.03 g/ml for all antimicro-
ial agents. The growth inhibition was demonstrated by opticalcine 21 (2013) 25– 29
density at 630 nm using a microplate reader (Thermo plate –
TP Reader®). Considering the total growth (100%) in the con-
trol well (MHB + bacteria), the percentage of growth reduction
was attributed to the remaining wells. Control solution contain-
ing dimethylsulfoxide/tween80/H2O (1.0/0.5/8.5) was included in
this experiment to exclude the possibility of toxic effects on the
microorganisms.
The MIC  was  reported as the lowest concentration of lapa-
chol, -lapachone and -lapachone or antimicrobial agents that
inhibited the bacterial growth after 24 h of incubation at 37 ◦C. In
order to determine the Minimal Bactericidal Concentration (MBC),
the contents of the wells that showed higher or equal than 70% of
growth inhibition were seeded onto Mueller-Hinton Agar (MHA).
After 24 h of incubation at 37 ◦C, the number of surviving S. aureus
was determined. The MBC  value was deﬁned as the lowest con-
centration of the drugs at which 99.9% of the bacteria have been
killed. All experiments were carried out in duplicate on two differ-
ent days. With this study, the most active naphthoquinone against
MRSA strains was  selected for the synergic activity assay.
Checkerboard assay
Combinations of -lapachone and antimicrobial agents were
tested by using the checkerboard method. Appropriate dilutions of
-lapachone and antimicrobial agents were performed into MHB.
From these dilutions, 100 l aliquots were added into 96-well
microplates to obtain a ﬁnal concentration equal to the MIC or six
dilutions lower than the MIC  of the -lapachone and nine dilutions
lower than the MIC  of the antimicrobial agents. Each well received
5 l of the bacterial suspensions (104 CFU/well). Plates were incu-
bated for 24 h. The data were interpreted after calculating the FICI
values as follows: (MIC of the -lapachone in combination with
antimicrobial agents/MIC of the -lapachone) + (MIC of antimicro-
bial agents in combination with -lapachone/MIC of antimicrobial
agents). The combination was considered synergistic when the
FICI was ≤0.5; additive when it was  0.5 to ≤1 indifferent when
1 ≤ FICI ≤ 2 and, antagonistic when ≥2 (An et al. 2011).
Results
Antimicrobial activity
MIC  and MBC  values of the naphthoquinones and antimicrobial
agents against twelve S. aureus strains are shown in Table 1.
-Lapachone, when compared to lapachol and -lapachone,
showed the strongest anti-MRSA whose MIC  values ranged from
8.0 to 32 g/ml.
The Staphylococcus aureus strains revealed a resistance pro-
ﬁle against most antimicrobial agents tested, in particular to the
beta-lactam antibiotics. The MIC  values for ampicillin and cefoxitin
ranged from 4.0 to 512 g/ml, which showed to be less effec-
tive against the S. aureus strains tested. For amoxicillin/clavulanic
acid the values ranged from 4.0 to 64 g/ml. Among all S. aureus
strains tested, seven showed to be resistant to ciproﬂoxacin. For
meropenem, MIC  values ranged from 4.0 to 32 g/ml. All strains
showed to be sensitive to gentamicin, except LFBM 01, LFBM 26,
LFBM 28, and LFBM 33 strains.
Four strains (LFBM 01, LFBM 26, LFBM 28, and LFBM 33)
showed resistance to all antimicrobial agents tested. These Staphy-
lococcus aureus strains and the Staphylococcus aureus LFBM 31
strain, which proved to be the most resistant to beta -lapachone
(MIC = 32 g/ml), were selected for the study of the interaction
between -lapachone and antimicrobial agents. MBC  values were
one dilution higher than the respective MICs.
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Table 1
MIC/MBC of three naphthoquinones and antimicrobial agents against multidrug resistant Staphylococcus aureus strains.
Staphylococcus aureus MIC/MBC (g/ml) Resistance phenotypea
AMC  AMP  CFO CIP GET MER  LAP -LAP -LAP
ATCC 25923 4.0/8.0 4.0/8.0 4.0/8.0 4.0/8.0 4.0/8.0 4.0/8.0 256/512 64/128 8.0/16 Control strain
LFBM 01 32/64 512/1024 256/512 64/128 16/32 32/64 512/1024 128/256 8.0/16 AMC, CFO, CIP, GET
LFBM  05 8.0/16 128/256 32/64 4.0/8.0 4.0/8.0 16/32 512/1024 64/128 8.0/16 AMP, AZI, CFO, PEN
LFBM  08 4.0/8.0 128/256 16/32 4.0/8.0 4.0/8.0 8.0/16 256/512 128/256 16/32 AMP, AZI, CIP, CFO
LFBM  16 16/32 32/64 16/32 4.0/8.0 4.0/8.0 8.0/16 512/1024 128/256 8.0/16 AMP, AZI, CFO, PEN
LFBM  26 64/128 512/1024 256/512 64/128 32/64 32/64 512/1024 128/256 16/32 AMC, AMP, CFO, CIP
LFBM  28 32/64 512/1024 128/256 64/128 32/64 16/32 512/1024 256/512 8.0/16 AMC, CIP, CFO, GET
LFBM  29 16/32 64/128 32/64 4.0/8.0 4.0/8.0 16/32 512/1024 256/512 16/32 AMC, AMP, CFO, PEN
LFBM  30 16/32 256/512 16/32 64/128 4.0/8.0 16/32 256/512 256/512 16/32 AMC, AMP, CFO, CIP
LFBM  31 16/32 128/256 16/32 64/128 4.0/8.0 8.0/16 512/1024 256/512 32/64 AMP, AZI, CFO, CIP;
LFBM  32 16/32 256/512 16/32 64/128 4.0/8.0 16/32 256/512 128/256 16/32 AMP, CFO, CIP, PEN
LFBM  33 16/32 256/512 128/256 64/128 64/128 16/32 256/512 128/256 16/32 AMC, AMP, CFO, CIP
MIC: Minimal Inhibitory Concentration; MBC: Minimal Bactericidal Concentration; ATCC: American Type Culture Collection; LFBM: Laboratório de Fisiologia e Bioquímica
de  Micro-organismos; AMC: amoxicillin/clavulanic acid; AMP: ampicillin; AZI: azithromycin; CFO: cefoxitin; CIP: ciproﬂoxacin; GET: gentamicin; PEN: penicillin; MER:
meropenem; LAP: lapachol; -LAP.: -lapachone; -LAP: -lapachone.
a Resistance phenotype determined by the disk-diffusion method.
Table 2
Combination testing of the -lapachone with antimicrobial agents against MRSA strains.
Staphylococcus aureus Combination Combination MIC  (g/ml) Individual FIC FICI
LFBM 01
-Lap/AMP 1.0/64 0.125/0.125 0.25
-Lap/CIP 2.0/8.0 0.25/0.125 0.37
-Lap/AMC 2.0/2.0 0.25/0.06 0.31
-Lap/MER 2.0/4.0 0.25/0.125 0.37
-Lap/CFO 4.0/0.5 0.5/0.003 0.50
LFBM  26
-Lap/AMP 4.0/64 0.25/0.125 0.37
-Lap/CIP 4.0/0.5 0.25/0.007 0.25
-Lap/AMC 0.5/2.0 0.03/0.125 0.15
-Lap/MER 4.0/0.5 0.25/0.015 0.26
-Lap/CFO 4.0/1.0 0.25/0.003 0.25
LFBM  28
-Lap/AMP 2.0/64 0.25/0.125 0.37
-Lap/CIP 2.0/8.0 0.25/0.125 0.37
-Lap/AMC 0.5/0.5 0.06/0.015 0.07
-Lap/MER 2.0/1.0 0.25/0.06 0.31
LFBM  31
-Lap/AMP 8.0/16 0.25/0.125 0.37
-Lap/CIP 8.0/8.0 0.25/0.125 0.37
-Lap/AMC 1.0/2.0 0.03/0.125 0.15
-Lap/MER 1.0/0.5 0.03/0.06 0.09
LFBM  33
-Lap/AMP 4.0/32 0.25/0.125 0.37
-Lap/CIP 2.0/4.0 0.5/0.06 0.56
-Lap/AMC 0.5/2.0 0.03/0.125 0.15
-Lap/MER 4.0/0.5 0.25/0.03 0.09
M MP: ampicillin; CIP: ciproﬂoxacin; AMC: amoxicillin/clavulanic acid; MER: meropenem;
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heckerboard assay
The MIC  and FIC index values obtained by the combination of
-lapachone with ampicillin, amoxicillin/clavulanic acid, cefoxitin,
iproﬂoxacin or meropenem, against S. aureus LFBM 01, LFBM 26,
FBM 28, LFBM 31 and LFBM 33 strains are listed in Table 2.
The subinhibitory concentrations of -lapachone (≤0.5 × MIC)
nhanced the anti-staphylococcal activity of all antimicrobial
gents except for the combination with cefoxitin against LFBM 31
nd LFBM 33 strains. The synergistic activity was detected by a
eduction percentage in the MIC  values ≥87.5% for all antimicro-
ial agents in the combination with -lapachone and determined
y the FICI ≤ 0.5.
A strong synergistic activity was observed with the combina-
ion -lapachone–amoxicillin/clavulanic acid against the LFBM 28
train (FICI = 0.07) (Fig. 1).
The combination -lapachone–meropenem showed the higher
ctivity against LFBM 31 and LFBM 33 strains (FICI = 0.09).
or these microorganisms, the MIC  of meropenem (individual
Amoxilli n/clavulanic acid (FIC B)
Fig. 1. Isobole curve revealing the synergistic effect of -lapachone with amoxi-
cillin/clavulanic acid against Staphylococcus aureus LFBM 28 strain.
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IC  8–16 g/ml) was lowered to 1/128-fold (combined MIC
.06–0.03 g/ml), when it was used in combination with -
apachone.
The growth inhibition of all S. aureus strains by ciproﬂoxacin was
nhanced by -lapachone which displayed FICI values ranging from
.25 to 0.37. For S. aureus LFBM 33, this combination showed an
dditive effect (FICI = 0.56). In this case, -lapachone enhanced the
iproﬂoxacin antimicrobial activity once it resulted in a reduction
ercent of MIC  value of this ﬂuorquinolone equal to 93.7%.
The combination -lapachone–cefoxitin showed an indifferent
ffect against LFBM 31 and LFBM 33 strains. However, for the
FBM 31 strain, -lapachone tested at MIC  = 32 g/ml was able to
ower the MIC  of cefoxitin (individual MIC  = 16 g/ml; combined
IC  = 0.125 g/ml).
For the majority of combinations, -lapachone (0.5 × MIC) in
ssociation with the antimicrobial agents were able to reduce the
iable cells of MRSA strains to values ≥71.03% and demonstrated
ynergistic activity with FICI ≤ 0.5.
iscussion
Staphylococcus aureus remains a major nosocomial pathogen in
uman infections and its resistance to antibiotics constitutes a seri-
us problem for clinicians and microbiologists. These pathogens
re most frequently isolated from nosocomial infections, mainly
acteremia and sepsis (Naber 2009) with a considerable mortality
ate of 42% due to MRSA strains (Diekema et al. 2001; Nunes et al.
002).
The anti-MRSA therapy is limited to the use of glycopep-
ides (vancomycin, teicoplanin), oxazolidine (linezolide) and
uinupristin–dalfopristin. However, some MRSA strains resistant
o glycopeptides have been reported in Brazil (Nunes et al. 2002)
nd other countries (Coombs et al. 2011). This fact has stimulated
he research for new molecules and therapeutic schemes to pro-
ote more effective and less toxic regimes.
Plants and their secondary metabolites are a promising source
o provide structurally diverse bioactive compounds as potentially
herapeutic agents, including antimicrobials (Cowan 1999; Wink
t al. 2012).
Naphthoquinones are a class of secondary metabolites widely
ound in higher plants, microorganisms, and some animals and
ave been used in cosmetics, foods, and pharmaceutics products
Ferreira et al. 2010). A variety of the naphthoquinones that occur
aturally, such as lapachol, -lapachone, -lapachone, juglone, and
ublagin, obtained from plant extracts, have prompted an increas-
ng interest to researchers around the world due to their large
tructural diversity and biological activities. This fact has been
roven by the large number of scientiﬁc papers published on this
ubject in recent years (Wink et al. 2012; Kumagai et al. 2012;
erreira et al. 2010).
In this work the MIC  values of lapachol, -lapachone and
-lapachone were determined by the broth dilution method.
ccording to Sartoratto et al. (2004), a strong activity is achieved
or MIC  values between 50 and 500 g/ml, moderate activity for
IC  values between 600 and 1500 g/ml and weak activity, above
500 g/ml. Comparing with the literature data, our results showed
hat  and -lapachone have a strong activity whereas lapachol a
oderate activity against MRSA strains tested. Similar MIC  values
62.5 g/ml for -lapachone and 8 g/ml for -lapachone) were
lso obtained by Machado et al. (2003) and Pereira et al. (2006)
gainst MRSA strains.Naphthoquinones increase the generation of reactive oxygen
pecies that damage lipids, proteins and deoxyribonucleic acids.
hey are also known to form irreversible complexes with nucleo-
hilic amino acids in proteins, often leading to inactivation of thecine 21 (2013) 25– 29
protein and loss of its function. For that reason, the potential range
of the quinone antimicrobial effect is great. Possible targets in
the microbial cell are surface-exposed adhesins, cell wall polypep-
tides, and membrane-bound enzymes, as well as render substrates
unavailable to microorganisms (Cowan 1999).
Pereira et al. (2006) showed that the synthesis of bacterial
protein was not inhibited by divers naphthoquinones including -
lapachone. However, he observed that some proteins of molecular
weight of 100, 70, 60, and 10 kDa had their levels increased. These
proteins are associated with oxidative stress induced by naph-
thoquinones in all strains of Staphylococcus.  Naphthoquinones can
compete with ubiquinone, an electron transfer substance present
in the respiratory electron transport chain, affecting the ATP syn-
thesis.
The interactions of plant isolated compounds and antimicro-
bial agents have been evaluated against an array of resistant
microorganisms. These studies are not exclusive for extracts, since
effective combinations between single compound or essential oils
and conventional antimicrobials have been recently published
(Cho et al. 2011; An et al. 2011; Duarte et al. 2012; Fadli et al.
2012).
The majority of plant secondary metabolites have weak antimi-
crobial activity. Despite this observation, they are able to ﬁght
infections caused by fungi and bacteria. Hence, it appears that
plants adopt synergistic mechanisms between their bioactive
compounds (Wagner and Ulrich-Merzenich 2009).
According to some authors, although the plant extract in asso-
ciation with antimicrobial agents, having different target sites,
show different degrees of antibacterial activity, the ability of these
antibacterial combinations to inhibit resistant bacteria showed
that they have either attacked different target sites singly or com-
bined to overcome inherent resistant mechanisms in the isolates
(Olufunmiso and Afolayan 2012).
In a previous study, we  described the synergistic effect between
-lapachone and isoniazide against Mycobacterium fortuitum and
Mycobacterium smegmatis.  This combination presented a bacteri-
cidal activity and was able to sterilize the mycobacterial cultures
in 96 h (Silva et al. 2009).
In the present study, a growth inhibitory effect of -lapachone
on MRSA strains was  observed for the combinations with beta-
lactams, carbapenems, and ﬂuoroquinolones. These results are in
agreement with those published by Lee et al. (2010) and Wink
et al. (2012). These authors showed that the combinations between
some naphthoquinones from plants and  lactams (ampicillin and
oxacillin) are synergistic when they were tested against MRSA
strains.
The synergistic effect between natural products and antimi-
crobial agents are a thrust area of phytomedical research with a
prospect for developing new drugs. Due to the increase prevalence
of multi-drug resistant microorganisms, synergism testing using
various combinations of phytochemicals with antimicrobial agents
could be a powerful tool in helping to select an antimicrobial ther-
apy more effective and less toxic (Hemaiswarya et al. 2008; Wagner
and Ulrich-Merzenich 2009).
Conclusion
An antibacterial effect of -lapachone and its synergistic effect
when in combination with antimicrobial agents were observed in
this study. These results may  be applied in the near future in alter-In addition, more studies including structural molecular modiﬁ-
cation, together with toxicological and pharmaceutical technology
studies should be conducted on this molecule before its therapeutic
application.
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